Sonoma Pharmaceuticals Inc (SNOA)
0.1602
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
0.1602
0.00 (0.00%)
After-Hours: 17:11
Sonoma Pharmaceuticals Cash from Operations (TTM): -4.991M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -4.991M |
September 30, 2023 | -4.235M |
June 30, 2023 | -4.834M |
March 31, 2023 | -6.152M |
December 31, 2022 | -5.106M |
September 30, 2022 | -5.084M |
June 30, 2022 | -4.558M |
March 31, 2022 | -4.248M |
December 31, 2021 | -4.329M |
September 30, 2021 | -3.257M |
June 30, 2021 | -2.31M |
March 31, 2021 | -3.378M |
December 31, 2020 | -5.493M |
September 30, 2020 | -7.079M |
June 30, 2020 | -7.62M |
March 31, 2020 | -4.591M |
December 31, 2019 | -3.746M |
September 30, 2019 | -5.27M |
June 30, 2019 | -7.919M |
March 31, 2019 | -11.72M |
December 31, 2018 | -12.02M |
September 30, 2018 | -11.81M |
June 30, 2018 | -10.86M |
March 31, 2018 | -12.44M |
December 31, 2017 | -12.09M |
Date | Value |
---|---|
September 30, 2017 | -11.40M |
June 30, 2017 | -10.42M |
March 31, 2017 | -8.167M |
December 31, 2016 | -7.194M |
September 30, 2016 | -8.414M |
June 30, 2016 | -8.538M |
March 31, 2016 | -8.746M |
December 31, 2015 | -9.654M |
September 30, 2015 | -8.018M |
June 30, 2015 | -7.933M |
March 31, 2015 | -6.694M |
December 31, 2014 | -5.553M |
September 30, 2014 | -5.445M |
June 30, 2014 | -5.179M |
March 31, 2014 | -4.89M |
December 31, 2013 | -4.445M |
September 30, 2013 | -4.596M |
June 30, 2013 | 1.357M |
March 31, 2013 | 1.15M |
December 31, 2012 | 0.88M |
September 30, 2012 | 0.728M |
June 30, 2012 | -4.767M |
March 31, 2012 | -4.032M |
December 31, 2011 | -2.792M |
September 30, 2011 | -3.175M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-7.919M
Minimum
Jun 2019
-2.31M
Maximum
Jun 2021
-4.958M
Average
-4.834M
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Oragenics Inc | -7.291M |